Teijin Pharma Ltd
Teijin Pharma Ltd., a prominent player in the pharmaceutical industry, is headquartered in Japan (JP) and operates extensively across Asia, Europe, and North America. Founded in 2002, the company has established itself as a leader in innovative healthcare solutions, focusing on areas such as oncology, central nervous system disorders, and regenerative medicine. Teijin Pharma is renowned for its unique core products, including advanced biopharmaceuticals and specialty pharmaceuticals that address unmet medical needs. The company’s commitment to research and development has led to significant milestones, enhancing its market position and reputation for quality. With a strong emphasis on patient-centric solutions, Teijin Pharma continues to make notable contributions to global health, solidifying its status as a trusted name in the pharmaceutical sector.
DitchCarbon Score
How does Teijin Pharma Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Teijin Pharma Ltd's score of 3 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Teijin Pharma Ltd's reported carbon emissions
Teijin Pharma Ltd, headquartered in Japan, currently does not have publicly available data on its carbon emissions, including specific figures for Scope 1, 2, or 3 emissions. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This lack of information suggests that the company may still be in the early stages of formalising its climate commitments or reporting on its emissions. As the industry increasingly prioritises sustainability, it is essential for Teijin Pharma Ltd to establish clear targets and transparent reporting to align with global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Teijin Pharma Ltd is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
